Patients with stage III and IV cancer have worse quality of life during the COVID-19 pandemic.
The FDA has approved an expanded indication for Gardasil 9® (human papillomavirus 9-valent vaccine [HPV], recombinant; Merck) to include the prevention of oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, and 58 in patients aged 9 to 45 years.
Readmissions for CRS, neurotoxicity, infection, and other adverse events are common after immunotherapy with axicabtagene ciloleucel.
Breast cancer surgery is safe in women 70 years and older.
Patients with early-stage breast cancer who undergo mastectomy with or without reconstruction are at risk of prolonged opioid use.
The risk of developing benign ovarian cysts is up to 90% for premenopausal women and 75% for postmenopausal women.
Insulin resistance is one factor mediating part of the association between race and poor prognosis in breast cancer.
Previous studies investigated the benefits of CBT delivered by clinical psychologists. In this study, researchers sought to determine its benefits when delivered by breast care nurses trained in the intervention.
Women with screening-detected ductal carcinoma in situ have increased long-term risks for invasive breast cancer and breast cancer death.
The diet and physical activity guideline for the prevention of cancer has been updated by the American Cancer Society.
Prescription drug monitoring programs that aim to prevent opioid misuse may be affecting patients with cancer who need pain management.
These study findings show that weight loss occurred early among patients with advanced gastric cancer and was associated with shorter overall survival.
Investigators suggest more personalized interventions may be needed to improve adherence rates among women with breast cancer receiving AI treatments.
Multiple genes predispose African-American women to breast cancer.
This study also showed a gradual increase in cognitive impairment at 12 months that persisted at 24 and 36 months for patients receiving endocrine therapy alone.
Nearly half of cancer research has been stopped due to the COVID-19 pandemic.
Women participating in mammography screening have a significant reduction in the risk for dying of breast cancer and in the rate of advanced breast cancers.
Exact risk-adapted starting ages for CRC could be used to better counsel individuals about the appropriate age to be screened.
Survivors of childhood hematologic malignancies with poorly reported patient outcomes may have more chronic health conditions, regardless of treatment method.
In guidance issued by the COVID-19 Pandemic Breast Cancer Consortium, recommendations are presented for prioritizing care for breast cancer patients during the COVID-19 pandemic.